COVID-19 infection rate in patients treated with DMARDs consistent with general population

The incidence and severity of COVID-19 among patients with rheumatic disease treated with targeted synthetic or biological DMARDs is consistent with those in the general population, according to data published in Arthritis & Rheumatology.“Along with the growth of the worldwide health emergency, there has been an increasing need to clarify the incidence and course of COVID-19 in

Read the full article here

Related Articles